A chartered accountant and his scientist partner are to earn £30m after
selling their company to bio-tech company, ML Laboratories.
The two, Rajan Uppal and Terrence Chadwick, bought Quadrant Technologies in
2003 and own a 64% controlling stake in the private company.
It has developed a method of stabilising drugs so they can be administered to
asthmatics via their inhalers, the technique understood to have prompted the
£46m offer from ML.
Uppal, 42, specialises in corporate finance and is understood to be the
business brains behind Quadrant. Chadwick, a former physician who develops new
formulations for drugs, is the creative force.
The two have accepted the offer from ML, which is likely to use Quadrant as a
basis of rebuilding its loss making business.
The Financial Reporting Council has issued guidance regarding the annual reporting of 1,200 large and smaller listed companies. The letter highlighted the key issues and improvements that can be made in the 2016 reporting season
Baldwins Accountancy Group has continued investment in the north-east and appointed David Fish as a director in its corporate finance team
UK M&A activity bounced back strongly in July and August, according to analysis by the deals practice at PwC.
Smith & Williamson has added Jim Clark and Philip Marsden, of Marsden Clark Corporate Finance Limited, to its corporate finance team.